Top compounds associated with response to POLR2F


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.06
mRNA RITA CTRPv2 pan-cancer AAC -0.074 0.06
mRNA ML162 CTRPv2 pan-cancer AAC -0.068 0.07
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.081 0.07
mRNA Nilotinib CCLE pan-cancer AAC -0.12 0.07
mRNA A-804598 CTRPv2 pan-cancer AAC -0.093 0.07
mRNA GSK4112 CTRPv2 pan-cancer AAC -0.074 0.07
mRNA paclitaxel CCLE pan-cancer AAC -0.1 0.07
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.069 0.07
Download CSV